Abstract
Summary
The Asia-Pacific medical cannabis market is expected to reach USD 13,419.95 million by 2030 from USD 2,696.34 million in 2022, growing at a CAGR of 22.3% during the forecast period of 2023 to 2030.
Market Segmentation
Asia-Pacific Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, and Rest of Asia-Pacific) – Industry Trends and Forecast to 2030
Overview of Asia-Pacific Medical Cannabis Market Dynamics
Driver
• Increased medical use of cannabis
Restraint
• The complex regulatory structure for the usage of cannabis
Opportunity
• Novel product development with increasing R&D activities
Market Players
Some of the major market players operating in the Asia-Pacific medical cannabis market are:
• MediPharm Labs Inc.
• Tilray
• Aurora Cannabis
• JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)
• HEXO Corp. (Zenabis Global Ltd)
• Cresco Labs
• Peace Naturals Project Inc.
• CANOPY GROWTH CORPORATION
• Medical Marijuana, Inc.
• Seed Cellar
• EcoGen Biosciences
• CANNABIS SEEDS USA
• Seeds For Me
• HUMBOLDT SEED COMPANY
• Extractas
• World Class Cannabis Seeds (Crop King Seeds)
• BARNEY'S FARM
• FOLIUM BIOSCIENCES
• PharmaHemp
• Elixinol Global Limited
• ENDOCA
• Harmony
• MARY’S nutritionals, LLC
• Pure Ratios
• Greenwich Biosciences, Inc.
• Upstate Elevator Supply Co.
• Apothecanna
• BOL Pharma
• IDT Australia
Table of Contents
1 INTRODUCTION 156
1.1 OBJECTIVES OF THE STUDY 156
1.2 MARKET DEFINITION 156
1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET 156
1.4 LIMITATIONS 158
1.5 MARKETS COVERED 159
2 MARKET SEGMENTATION 168
2.1 MARKETS COVERED 168
2.2 GEOGRAPHICAL SCOPE 169
2.3 YEARS CONSIDERED FOR THE STUDY 170
2.4 CURRENCY AND PRICING 170
2.5 DBMR TRIPOD DATA VALIDATION MODEL 171
2.6 MULTIVARIATE MODELLING 174
2.7 PRODUCT LIFELINE CURVE 174
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 175
2.9 DBMR MARKET POSITION GRID 176
2.10 MARKET APPLICATION COVERAGE GRID 178
2.11 VENDOR SHARE ANALYSIS 179
2.12 SECONDARY SOURCES 180
2.13 ASSUMPTIONS 180
3 EXECUTIVE SUMMARY 181
4 PREMIUM INSIGHTS 184
4.1 PESTEL ANALYSIS 185
4.2 PORTER’S FIVE FORCES 186
5 INDUSTRY INSIGHTS 187
5.1 INDUSTRY INSIGHTS PATENT ANALYSIS 187
5.2 DRUG TREATMENT RATE BY MATURED MARKETS 194
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 195
5.4 PATIENT FLOW DIAGRAM 196
5.5 KEY PRICING STRATEGIES 197
5.6 KEY PATIENT ENROLLMENT STRATEGIES 198
6 REGULATORY SCENARIO 199
6.1 AUSTRALIA 199
6.2 THAILAND 199
6.3 JAPAN 199
6.4 CHINA 199
6.5 NEW ZEALAND 200
6.6 SINGAPORE 200
6.7 INDIA 200
6.8 MALAYSIA 200
6.9 PHILIPPINES 200
7 MARKET OVERVIEW 201
7.1 DRIVERS 202
7.1.1 INCREASED USE OF CANNABIS IN MEDICINES 202
7.1.2 LEGALIZATION OF CANNABIS 202
7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS 202
7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 203
7.2 RESTRAINTS 204
7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS 204
7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE 204
7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY 205
7.3 OPPORTUNITIES 205
7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES 205
7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES 205
7.3.3 GROWING GERIATRIC POPULATION 206
7.4 CHALLENGES 206
7.4.1 RISE OF THE CANNABIS BLACK MARKET 206
7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS 207
7.4.3 SHORTAGE OF SKILLED PERSONNEL 207
8 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT 208
8.1 OVERVIEW 209
8.2 OIL 213
8.2.1 OIL, BY TYPE 213
- 8.2.1.1 CBD OIL CONCENTRATES 213
- 8.2.1.2 CBD VAPE OIL 214
- 8.2.1.3 CBD TINCTURES 214
8.2.2 OIL, BY SOURCE 214
- 8.2.2.1 HEMP BASED 214
- 8.2.2.2 MARIJUANA BASED 214
8.2.3 OIL, BY SPECIES 214
- 8.2.3.1 SATIVA 214
- 8.2.3.2 HYBRID 215
- 8.2.3.3 CANNABIS INDICA 215
8.2.4 OIL, BY PRODUCT TYPE 215
- 8.2.4.1 BRANDED 215
- 8.2.4.1.1 PENGUIN CBD OIL 215
- 8.2.4.1.2 FAB CBD OIL 216
- 8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL 216
- 8.2.4.1.4 OTHERS 216
- 8.2.4.2 GENERIC 216
- 8.2.4.1 BRANDED 215
8.3 DRIED MEDICAL CANNABIS 216
8.3.1 CANNABIS INDICA 217
8.3.2 SATIVA 217
8.3.3 HYBRID 217
8.4 MEDICAL CANNABIS CAPSULES 218
8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE 218
- 8.4.1.1 OIL BASED CANNABIS CAPSULES 219
- 8.4.1.2 POWDER BASED CANNABIS CAPSULES 219
- 8.4.1.3 LIQUID BASED CANNABIS CAPSULES 219
- 8.4.1.4 OTHERS 219
8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES 219
- 8.4.2.1 HIGH CBD CAPSULES DIGITAL 219
- 8.4.2.2 HIGH THC CAPSULE 219
- 8.4.2.3 THC/CBD BALANCED CAPSULE 220
- 8.4.2.4 CBD ISOLATE CAPSULE 220
8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES 220
- 8.4.3.1 SATIVA 220
- 8.4.3.2 CANNABIS INDICA 220
8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE 220
- 8.4.4.1 BRANDED 221
- 8.4.4.1.1 JOY NUTRITION 221
- 8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES 221
- 8.4.4.1.3 LAZARUS NATURALS 221
- 8.4.4.1.4 OTHERS 221
- 8.4.4.2 GENERIC 221
- 8.4.4.1 BRANDED 221
8.5 VAPE PEN 221
8.5.1 VAPE PEN, BY SPECIES 222
- 8.5.1.1 SATIVA 222
- 8.5.1.2 HYBRID 222
- 8.5.1.3 CANNABIS INDICA 223
8.5.2 VAPE PEN, BY PRODUCT TYPE 223
- 8.5.2.1 BRANDED 223
- 8.5.2.1.1 KANDYPENS RUBI 223
- 8.5.2.1.2 SOL E-NECTAR COLLECTOR 223
- 8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN 224
- 8.5.2.2 GENERIC 224
- 8.5.2.1 BRANDED 223
8.6 WHOLE FLOWER 224
8.6.1 WHOLE FLOWER, SPECIES 224
- 8.6.1.1 SATIVA 225
- 8.6.1.2 HYBRID 225
- 8.6.1.3 CANNABIS INDICA 225
8.6.2 WHOLE FLOWER, PRODUCT TYPE 225
- 8.6.2.1 BRANDED 226
- 8.6.2.1.1 ASTER FARMS 226
- 8.6.2.1.2 RA FLOWER 226
- 8.6.2.1.3 BAD APPLE 226
- 8.6.2.2 GENERIC 226
- 8.6.2.1 BRANDED 226
8.7 CREAMS & MOISTURIZER 227
8.7.1 CREAMS & MOISTURIZER, BY SPECIES 227
- 8.7.1.1 SATIVA 228
- 8.7.1.2 HYBRID 228
- 8.7.1.3 CANNABIS INDICA 228
8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE 228
- 8.7.2.1 BRANDED 228
- 8.7.2.1.1 CBDFX MUSCLE & JOINT 229
- 8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM 229
- 8.7.2.1.3 MEDTERRA PAIN CREAM 229
- 8.7.2.2 GENERIC 229
- 8.7.2.1 BRANDED 228
8.8 GROUND FLOWER 229
8.8.1 GROUND FLOWER, BY SPECIES 230
- 8.8.1.1 SATIVA 230
- 8.8.1.2 HYBRID 230
- 8.8.1.3 CANNABIS INDICA 230
8.8.2 GROUND FLOWER, BY PRODUCT TYPE 230
- 8.8.2.1 BRANDED 231
- 8.8.2.1.1 ASTER FARMS 231
- 8.8.2.1.2 RA FLOWER 231
- 8.8.2.1.3 BAD APPLE 231
- 8.8.2.2 GENERIC 231
- 8.8.2.1 BRANDED 231
8.9 PATCH 232
8.9.1 PATCH, BY TYPE 232
- 8.9.1.1 RESERVOIR 232
- 8.9.1.2 LAYER DRUG-IN-ADHESIVE 232
- 8.9.1.3 OTHERS 233
8.9.2 PATCH, BY SPECIES 233
- 8.9.2.1 SATIVA 233
- 8.9.2.2 CANNABIS INDICA 233
- 8.9.2.3 HYBRID 233
8.9.3 PATCH, BY PRODUCT TYPE 233
- 8.9.3.1 BRANDED 233
- 8.9.3.1.1 HEMP BOMBS 234
- 8.9.3.1.2 PUREKANA 234
- 8.9.3.1.3 PURE RATIOS 234
- 8.9.3.1.4 RESERVOIR 234
- 8.9.3.2 GENERIC 234
- 8.9.3.1 BRANDED 233
8.10 MASKS & SERUM 235
8.10.1 MASKS & SERUM, BY SPECIES 235
- 8.10.1.1 SATIVA 236
- 8.10.1.2 CANNABIS INDICA 236
- 8.10.1.3 HYBRID 236
8.10.2 MASKS & SERUM, BY PRODUCT TYPE 236
- 8.10.2.1 BRANDED 236
- 8.10.2.1.1 BUMP & SMOOTH CBD 236
- 8.10.2.1.2 FACIAL ESSENCE 237
- 8.10.2.1.3 OTHERS 237
- 8.10.2.2 GENERIC 237
- 8.10.2.1 BRANDED 236
8.11 CLEANSER 237
8.11.1 CLEANSER, BY SPECIES 237
- 8.11.1.1 SATIVA 238
- 8.11.1.2 HYBRID 238
- 8.11.1.3 CANNABIS INDICA 238
8.11.2 CLEANSER, BY PRODUCT TYPE 238
- 8.11.2.1 BRANDED 239
- 8.11.2.1.1 KIEHL’S 239
- 8.11.2.1.2 CBD 101 239
- 8.11.2.1.3 OTHERS 239
- 8.11.2.2 GENERIC 239
- 8.11.2.1 BRANDED 239
8.12 OTHERS 240
9 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES 241
9.1 OVERVIEW 242
9.2 SATIVA 245
9.3 HYBRID 246
9.4 CANNABIS INDICA 247
10 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES 248
10.1 OVERVIEW 249
10.2 CANNABIDIOL (CBD) 252
10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL 252
10.4 CANNABIGEROL (CBG) 253
10.5 CANNABICHROMENE (CBC) 254
10.6 CANNABINOL (CBN) 255
10.7 CANNABICYCLOL (CBL) 256
10.8 OTHERS 257
11 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION 258
11.1 OVERVIEW 259
11.2 PAIN MANAGEMENT 263
11.2.1 PAIN MANAGEMENT, BY TYPE 263
- 11.2.1.1 CHRONIC PAIN 263
- 11.2.1.2 NON-CANCER CHRONIC PAIN 264
- 11.2.1.3 NEUROLOGICAL PAIN 264
11.2.2 PAIN MANAGEMENT, BY PRODUCT 264
- 11.2.2.1 OIL 264
- 11.2.2.2 DRIED MEDICAL CANNABIS 264
- 11.2.2.3 MEDICAL CANNABIS CAPSULES 264
- 11.2.2.4 PATCH 265
- 11.2.2.5 GROUND FLOWER 265
- 11.2.2.6 CREAMS & MOISTURIZER 265
- 11.2.2.7 VAPE PEN 265
- 11.2.2.8 WHOLE FLOWER 265
- 11.2.2.9 MASKS & SERUM 265
- 11.2.2.10 CLEANSER 265
- 11.2.2.11 OTHERS 265
11.3 ANXIETY 265
11.3.1 OIL 266
11.3.2 DRIED MEDICAL CANNABIS 266
11.3.3 MEDICAL CANNABIS CAPSULES 267
11.3.4 PATCH 267
11.3.5 GROUND FLOWER 267
11.3.6 CREAMS & MOISTURIZER 267
11.3.7 VAPE PEN 267
11.3.8 WHOLE FLOWER 267
11.3.9 MASKS & SERUM 267
11.3.10 CLEANSER 267
11.3.11 OTHERS 267
11.4 MUSCLE SPASM 268
11.4.1 OIL 269
11.4.2 DRIED MEDICAL CANNABIS 269
11.4.3 MEDICAL CANNABIS CAPSULES 269
11.4.4 PATCH 269
11.4.5 GROUND FLOWER 269
11.4.6 CREAMS & MOISTURIZER 269
11.4.7 VAPE PEN 270
11.4.8 WHOLE FLOWER 270
11.4.9 MASKS & SERUM 270
11.4.10 CLEANSER 270
11.4.11 OTHERS 270
11.5 NAUSEA 270
11.5.1 OIL 271
11.5.2 DRIED MEDICAL CANNABIS 271
11.5.3 MEDICAL CANNABIS CAPSULES 271
11.5.4 PATCH 271
11.5.5 GROUND FLOWER 271
11.5.6 CREAMS & MOISTURIZER 272
11.5.7 VAPE PEN 272
11.5.8 WHOLE FLOWER 272
11.5.9 MASKS & SERUM 272
11.5.10 CLEANSER 272
11.5.11 OTHERS 272
11.6 APPETITE LOSS 272
11.6.1 OIL 273
11.6.2 DRIED MEDICAL CANNABIS 273
11.6.3 MEDICAL CANNABIS CAPSULES 274
11.6.4 PATCH 274
11.6.5 GROUND FLOWER 274
11.6.6 CREAMS & MOISTURIZER 274
11.6.7 VAPE PEN 274
11.6.8 WHOLE FLOWER 274
11.6.9 MASKS & SERUM 274
11.6.10 CLEANSER 274
11.6.11 OTHERS 274
11.7 EATING DISORDERS 275
11.7.1 OIL 276
11.7.2 DRIED MEDICAL CANNABIS 276
11.7.3 MEDICAL CANNABIS CAPSULES 276
11.7.4 PATCH 276
11.7.5 GROUND FLOWER 276
11.7.6 CREAMS & MOISTURIZER 277
11.7.7 VAPE PEN 277
11.7.8 WHOLE FLOWER 277
11.7.9 MASKS & SERUM 277
11.7.10 CLEANSER 277
11.7.11 OTHERS 277
11.8 INFLAMMATORY BOWEL DISEASES 277
11.8.1 OIL 278
11.8.2 DRIED MEDICAL CANNABIS 278
11.8.3 MEDICAL CANNABIS CAPSULES 279
11.8.4 PATCH 279
11.8.5 GROUND FLOWER 279
11.8.6 CREAMS & MOISTURIZER 279
11.8.7 VAPE PEN 279
11.8.8 WHOLE FLOWER 279
11.8.9 MASKS & SERUM 279
11.8.10 CLEANSER 279
11.8.11 OTHERS 279
11.9 CANCER 280
11.9.1 OIL 281
11.9.2 DRIED MEDICAL CANNABIS 281
11.9.3 MEDICAL CANNABIS CAPSULES 281
11.9.4 PATCH 281
11.9.5 GROUND FLOWER 281
11.9.6 CREAMS & MOISTURIZER 282
11.9.7 VAPE PEN 282
11.9.8 WHOLE FLOWER 282
11.9.9 MASKS & SERUM 282
11.9.10 CLEANSER 282
11.9.11 OTHERS 282
11.10 ARTHRITIS 282
11.10.1 OIL 283
11.10.2 DRIED MEDICAL CANNABIS 283
11.10.3 MEDICAL CANNABIS CAPSULES 283
11.10.4 PATCH 283
11.10.5 GROUND FLOWER 283
11.10.6 CREAMS & MOISTURIZER 284
11.10.7 VAPE PEN 284
11.10.8 WHOLE FLOWER 284
11.10.9 MASKS & SERUM 284
11.10.10 CLEANSER 284
11.10.11 OTHERS 284
11.11 WASHING SYNDROME (CACHEXIA) 284
11.11.1 OIL 285
11.11.2 DRIED MEDICAL CANNABIS 285
11.11.3 MEDICAL CANNABIS CAPSULES 285
11.11.4 PATCH 285
11.11.5 GROUND FLOWER 285
11.11.6 CREAMS & MOISTURIZER 286
11.11.7 VAPE PEN 286
11.11.8 WHOLE FLOWER 286
11.11.9 MASKS & SERUM 286
11.11.10 CLEANSER 286
11.11.11 OTHERS 286
11.12 ALZHEIMER’S DISEASE 286
11.12.1 OIL 287
11.12.2 DRIED MEDICAL CANNABIS 287
11.12.3 MEDICAL CANNABIS CAPSULES 288
11.12.4 PATCH 288
11.12.5 GROUND FLOWER 288
11.12.6 CREAMS & MOISTURIZER 288
11.12.7 VAPE PEN 288
11.12.8 WHOLE FLOWER 288
11.12.9 MASKS & SERUM 288
11.12.10 CLEANSER 288
11.12.11 OTHERS 288
11.13 EPILEPSY 289
11.13.1 OIL 290
11.13.2 DRIED MEDICAL CANNABIS 290
11.13.3 MEDICAL CANNABIS CAPSULES 290
11.13.4 PATCH 290
11.13.5 GROUND FLOWER 290
11.13.6 CREAMS & MOISTURIZER 291
11.13.7 VAPE PEN 291
11.13.8 WHOLE FLOWER 291
11.13.9 MASKS & SERUM 291
11.13.10 CLEANSER 291
11.13.11 OTHERS 291
11.14 DEPRESSION AND SLEEP DISORDER 291
11.14.1 OIL 292
11.14.2 DRIED MEDICAL CANNABIS 292
11.14.3 MEDICAL CANNABIS CAPSULES 293
11.14.4 PATCH 293
11.14.5 GROUND FLOWER 293
11.14.6 CREAMS & MOISTURIZER 293
11.14.7 VAPE PEN 293
11.14.8 WHOLE FLOWER 293
11.14.9 MASKS & SERUM 293
11.14.10 CLEANSER 293
11.14.11 OTHERS 293
11.15 MULTIPLE SCLEROSIS 294
11.15.1 OIL 295
11.15.2 DRIED MEDICAL CANNABIS 295
11.15.3 MEDICAL CANNABIS CAPSULES 295
11.15.4 PATCH 295
11.15.5 GROUND FLOWER 295
11.15.6 CREAMS & MOISTURIZER 296
11.15.7 VAPE PEN 296
11.15.8 WHOLE FLOWER 296
11.15.9 MASKS & SERUM 296
11.15.10 CLEANSER 296
11.15.11 OTHERS 296
11.16 AUTISM 296
11.16.1 OIL 297
11.16.2 DRIED MEDICAL CANNABIS 297
11.16.3 MEDICAL CANNABIS CAPSULES 298
11.16.4 PATCH 298
11.16.5 GROUND FLOWER 298
11.16.6 CREAMS & MOISTURIZER 298
11.16.7 VAPE PEN 298
11.16.8 WHOLE FLOWER 298
11.16.9 MASKS & SERUM 298
11.16.10 CLEANSER 298
11.16.11 OTHERS 298
11.17 MENTAL HEALTH CONDITIONS 298
11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE 299
- 11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD) 299
- 11.17.1.2 SCHIZOPHRENIA 299
- 11.17.1.3 OTHERS 299
11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE 300
- 11.17.2.1 OIL 300
- 11.17.2.2 DRIED MEDICAL CANNABIS 300
- 11.17.2.3 MEDICAL CANNABIS CAPSULES 300
- 11.17.2.4 PATCH 300
- 11.17.2.5 GROUND FLOWER 300
- 11.17.2.6 CREAMS & MOISTURIZER 301
- 11.17.2.7 VAPE PEN 301
- 11.17.2.8 WHOLE FLOWER 301
- 11.17.2.9 MASKS & SERUM 301
- 11.17.2.10 CLEANSER 301
- 11.17.2.11 OTHERS 301
11.18 ELEVATE MOOD 301
11.18.1 OIL 302
11.18.2 DRIED MEDICAL CANNABIS 302
11.18.3 MEDICAL CANNABIS CAPSULES 303
11.18.4 PATCH 303
11.18.5 GROUND FLOWER 303
11.18.6 CREAMS & MOISTURIZER 303
11.18.7 VAPE PEN 303
11.18.8 WHOLE FLOWER 303
11.18.9 MASKS & SERUM 303
11.18.10 CLEANSER 303
11.18.11 OTHERS 303
11.19 OTHERS 304
12 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION 305
12.1 OVERVIEW 306
12.2 ORAL SOLUTIONS AND CAPSULES 309
12.3 SMOKING 310
12.4 TOPICALS 310
12.5 VAPORIZERS 311
12.6 OTHERS 312
13 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE 313
13.1 OVERVIEW 314
13.2 ANALGESIC 317
13.3 PSYCHEDELIC 317
13.4 ANTIVIRAL 318
13.5 APHRODISIAC 319
13.6 EXPECTORANT 319
13.7 OTHERS 320
14 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER 321
14.1 OVERVIEW 322
14.2 HOMECARE SETTING 325
14.3 HOSPITAL 325
14.4 REHAB CENTERS 326
14.5 PHARMACEUTICAL INDUSTRY 327
14.6 RESEARCH AND DEVELOPMENT CENTERS 328
14.7 OTHERS 328
15 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL 329
15.1 OVERVIEW 330
15.2 B2C 333
15.2.1 PHARMACIES 334
15.2.2 CONVENTIONAL STORES 334
15.2.3 ONLINE STORES 334
15.2.4 OTHERS 334
15.3 B2B 334
16 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY REGION 335
16.1 ASIA-PACIFIC 336
16.1.1 AUSTRALIA 375
16.1.2 THAILAND 408
16.1.3 SOUTH KOREA 441
16.1.4 JAPAN 474
16.1.5 CHINA 507
16.1.6 NEW ZEALAND 540
16.1.7 SINGAPORE 573
16.1.8 INDIA 606
16.1.9 TAIWAN 639
16.1.10 MALAYSIA 672
16.1.11 PHILIPPINES 705
16.1.12 REST OF ASIA-PACIFIC 738
17 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE 739
17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 739
18 COMPANY PROFILE 740
18.1 MEDIPHARM LABS INC 740
18.1.1 COMPANY SNAPSHOT 740
18.1.2 REVENUE ANALYSIS 741
18.1.3 COMPANY SHARE ANALYSIS 741
18.1.4 PRODUCT PORTFOLIO 742
18.1.5 RECENT DEVELOPMENTS 742
18.2 TILRAY 744
18.2.1 COMPANY SNAPSHOT 744
18.2.2 COMPANY SHARE ANALYSIS 744
18.2.3 PRODUCT PORTFOLIO 745
18.2.4 RECENT DEVELOPMENTS 745
18.3 AURORA CANNABIS 746
18.3.1 COMPANY SNAPSHOT 746
18.3.2 REVENUE ANALYSIS 746
18.3.3 COMPANY SHARE ANALYSIS 747
18.3.4 PRODUCT PORTFOLIO 747
18.3.5 RECENT DEVELOPMENTS 747
18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC) 749
18.4.1 COMPANY SNAPSHOT 749
18.4.2 REVENUE ANALYSIS 749
18.4.3 COMPANY SHARE ANALYSIS 750
18.4.4 PRODUCT PORTFOLIO 750
18.4.5 RECENT DEVELOPMENTS 750
18.5 HEXO CORP. (ZENABIS ASIA PACIFIC LTD) 752
18.5.1 COMPANY SNAPSHOT 752
18.5.2 REVENUE ANALYSIS 752
18.5.3 COMPANY SHARE ANALYSIS 753
18.5.4 PRODUCT PORTFOLIO 753
18.5.5 RECENT DEVELOPMENTS 754
18.6 APOTHECANNA 755
18.6.1 COMPANY SNAPSHOT 755
18.6.2 PRODUCT PORTFOLIO 755
18.6.3 RECENT DEVELOPMENT 756
18.7 BOL PHARMA 757
18.7.1 COMPANY SNAPSHOT 757
18.7.2 PRODUCT PORTFOLIO 757
18.7.3 RECENT DEVELOPMENTS 757
18.8 BARNEY’S FARM 758
18.8.1 COMPANY SNAPSHOT 758
18.8.2 PRODUCT PORTFOLIO 758
18.8.3 RECENT DEVELOPMENTS 759
18.9 CANOPY GROWTH CORPORATION 760
18.9.1 COMPANY SNAPSHOT 760
18.9.2 REVENUE ANALYSIS 760
18.9.3 PRODUCT PORTFOLIO 761
18.9.4 RECENT DEVELOPMENTS 761
18.10 CANNABIS SEEDS USA 763
18.10.1 COMPANY SNAPSHOT 763
18.10.2 PRODUCT PORTFOLIO 763
18.10.3 RECENT DEVELOPMENT 765
18.11 CRESCO LABS 766
18.11.1 COMPANY SNAPSHOT 766
18.11.2 PRODUCT PORTFOLIO 766
18.11.3 RECENT DEVELOPMENTS 768
18.12 ECOGEN BIOSCIENCES 769
18.12.1 COMPANY SNAPSHOT 769
18.12.2 PRODUCT PORTFOLIO 769
18.12.3 RECENT DEVELOPMENTS 769
18.13 ELIXINOL ASIA PACIFIC LIMITED 770
18.13.1 COMPANY SNAPSHOT 770
18.13.2 REVENUE ANALYSIS 770
18.13.3 PRODUCT PORTFOLIO 771
18.13.4 RECENT DEVELOPMENTS 771
18.14 ENDOCA 772
18.14.1 COMPANY SNAPSHOT 772
18.14.2 PRODUCT PORTFOLIO 772
18.14.3 RECENT DEVELOPMENT 772
18.15 EXTRACTAS 773
18.15.1 COMPANY SNAPSHOT 773
18.15.2 PRODUCT PORTFOLIO 773
18.15.3 RECENT DEVELOPMENT 773
18.16 FOLIUM BIOSCIENCES 774
18.16.1 COMPANY SNAPSHOT 774
18.16.2 PRODUCT PORTFOLIO 774
18.16.3 RECENT DEVELOPMENTS 775
18.17 GREENWICH BIOSCIENCES, INC 776
18.17.1 COMPANY SNAPSHOT 776
18.17.2 PRODUCT PORTFOLIO 776
18.17.3 RECENT DEVELOPMENTS 776
18.18 HARMONY 777
18.18.1 COMPANY SNAPSHOT 777
18.18.2 PRODUCT PORTFOLIO 777
18.18.3 RECENT DEVELOPMENTS 777
18.19 HUMBOLDT SEED COMPANY 778
18.19.1 COMPANY SNAPSHOT 778
18.19.2 PRODUCT PORTFOLIO 778
18.19.3 RECENT DEVELOPMENT 779
18.20 IDT AUSTRALIA 780
18.20.1 COMPANY SNAPSHOT 780
18.20.2 REVENUE ANALYSIS 780
18.20.3 PRODUCT PORTFOLIO 781
18.20.4 RECENT DEVELOPMENTS 781
18.21 MARY’S NUTRITIONALS, LLC 783
18.21.1 COMPANY SNAPSHOT 783
18.21.2 PRODUCT PORTFOLIO 783
18.21.3 RECENT DEVELOPMENT 783
18.22 MEDICAL MARIJUANA, INC 784
18.22.1 COMPANY SNAPSHOT 784
18.22.2 REVENUE ANALYSIS 784
18.22.3 PRODUCT PORTFOLIO 785
18.22.4 RECENT DEVELOPMENTS 785
18.23 PEACE NATURALS PROJECT INC 786
18.23.1 COMPANY SNAPSHOT 786
18.23.2 PRODUCT PORTFOLIO 786
18.23.3 RECENT DEVELOPMENT 786
18.24 PHARMAHEMP 787
18.24.1 COMPANY SNAPSHOT 787
18.24.2 PRODUCT PORTFOLIO 787
18.24.3 RECENT DEVELOPMENT 787
18.25 PURE RATIOS 788
18.25.1 COMPANY SNAPSHOT 788
18.25.2 PRODUCT PORTFOLIO 788
18.25.3 RECENT DEVELOPMENT 788
18.26 SEEDS FOR ME 789
18.26.1 COMPANY SNAPSHOT 789
18.26.2 PRODUCT PORTFOLIO 789
18.26.3 RECENT DEVELOPMENT 789
18.27 SEED CELLAR 790
18.27.1 COMPANY SNAPSHOT 790
18.27.2 PRODUCT PORTFOLIO 790
18.27.3 RECENT DEVELOPMENT 791
18.28 UPSTATE ELEVATOR SUPPLY CO 792
18.28.1 COMPANY SNAPSHOT 792
18.28.2 PRODUCT PORTFOLIO 792
18.28.3 RECENT DEVELOPMENT 792
18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS) 793
18.29.1 COMPANY SNAPSHOT 793
18.29.2 PRODUCT PORTFOLIO 793
18.29.3 RECENT DEVELOPMENT 794
19 QUESTIONNAIRE 795
20 RELATED REPORTS 800